Rocket Lab SEC Filings

Rocket Lab reported record financial results for the first quarter ended March 31, 2026, surpassing all guidance metrics. The company achieved $200.3 million in revenue, a 63.5% increase year-over-year, and expanded its backlog to $2.2 billion. Strategic moves included the completion of the Mynaric acquisition and a definitive agreement to acquire Motiv Space Systems.

Revenue grew 63% year-over-year to $200.3 million, driven by strong performance in both Space Systems and Launch Services. Gross margins improved significantly to 38.2% compared to 28.8% in the prior year period. The company continues to operate at a net loss of $45.0 million for the quarter.

Rocket Lab Corporation has closed its acquisition of Mynaric AG, a German stock corporation. The deal was completed on April 14, 2026, for an aggregate consideration of $155.3 million. This transaction follows a Stock Purchase Agreement originally dated September 25, 2025.

This SEC Form 3 filing discloses the initial statement of beneficial ownership for Marvin Bradford Clevenger. Mr. Clevenger has assumed the role of President, Rocket Lab USA Inc., effective March 26, 2026. The filing is a regulatory requirement for new officers to declare their holdings in the company.

The 2026 proxy focuses on electing Edward H. Frank to the Board and approving a subsidiary merger to remove pass-through voting provisions. Governance highlights include maintaining an independent compensation committee and addressing a prior failed attempt to remove the same provision. Executive compensation emphasizes long-term equity alignment with no base salary increases in 2025.

The proxy outlines the election of Edward H. Frank to the Board for a term expiring in 2029. It also includes proposals for auditor ratification and a non-binding advisory vote on executive compensation.

Rocket Lab achieved record annual revenue of $601.8M, driven by 38% growth in space systems and launch services. Gross margins improved significantly to 34.4% from 26.6% in 2024, reflecting operational efficiencies and scale. The company maintains a strong liquidity position of $1.1B to support ongoing Neutron development.

Schedule 13D/A Amendment No. 5 by Peter Beck and affiliates updates beneficial ownership to 46.4M shares (7.51%). Disclosures include Equatorial Trust's new 10b5-1 plan to sell up to 5M common shares for diversification and philanthropy, and Beck's voluntary cancellation of 392,155 unvested RSUs to fund R&D. Relevant for investors tracking insider activity and alignment.

Rocket Lab amended CEO Sir Peter Beck's employment agreement, voluntarily reducing his base salary to $1 or New Zealand statutory minimum and eliminating bonus entitlements. Beck also forfeited all 392,155 unvested RSUs to redirect capital to strategic priorities and R&D. This aligns executive incentives with long-term shareholder value amid fiscal discipline.

This Schedule 13G/A (Amendment No. 5) discloses that The Vanguard Group beneficially owns 0 shares (0%) of Rocket Lab Corp's common stock as of March 13, 2026. The change results from Vanguard's internal realignment on January 12, 2026, where subsidiaries now report beneficial ownership separately per SEC Release No. 34-39538. Investors should note this is a reporting adjustment, not a reduction in underlying Vanguard-affiliated holdings.